Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,537 | -2,934 | -11,207 | -8,292 | -5,556 |
| Depreciation Amortization | 723 | 353 | 1,184 | 838 | 515 |
| Accounts receivable | -1,312 | 181 | 230 | -184 | 76 |
| Other Working Capital | -1,549 | 24 | -1,290 | -1,751 | -1,342 |
| Other Operating Activity | 2,167 | 346 | 2,761 | 2,306 | 1,687 |
| Operating Cash Flow | $-4,508 | $-2,030 | $-8,322 | $-7,083 | $-4,620 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,551 | 4,342 | 5,927 | 6,225 | 2,982 |
| PPE Investments | -761 | -373 | -2,664 | -2,480 | -2,145 |
| Purchase Of Investment | N/A | N/A | -1,000 | -1,000 | -1,000 |
| Other Investing Activity | -478 | -478 | 0 | 0 | 0 |
| Investing Cash Flow | $8,312 | $3,491 | $2,263 | $2,745 | $-163 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,433 | N/A | N/A |
| Debt Repayment | -283 | -117 | -201 | -88 | -57 |
| Common Stock Issued | 11 | N/A | 128 | 121 | 109 |
| Common Stock Repurchased | -2,783 | -476 | -1,077 | -384 | -20 |
| Financing Cash Flow | $-3,055 | $-593 | $1,283 | $-351 | $32 |
| Beginning Cash Position | 2,700 | 2,700 | 7,476 | 7,476 | 7,476 |
| End Cash Position | 3,449 | 3,568 | 2,700 | 2,787 | 2,725 |
| Net Cash Flow | $749 | $868 | $-4,776 | $-4,689 | $-4,751 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,508 | -2,030 | -8,322 | -7,083 | -4,620 |
| Capital Expenditure | -761 | -373 | -2,664 | -2,480 | -2,145 |
| Free Cash Flow | -5,269 | -2,403 | -10,986 | -9,563 | -6,765 |